Current news and events

Infrastructure grant from the Research Council of Norway:“ATMP Norway – A National Multimodal Infrastructure for ATMP” awarded 74 MNOK

Anna PasettoDirector of ACT
Anna Pasetto
Director of ACT

28 major projects now receive money for new and updated laboratories, equipment, databases and other research infrastructure. In total, the Norwegian Research Council will distribute NOK 1.3 billion. 

"We are excited to announce that the project “ATMP Norway – A National Multimodal Infrastructure for ATMP” has been awarded an infrastructure grant from the Research Council (74 MNOK)", says Anna Pasetto, Director of the Center for Advanced Cell Therapy (ACT) at the Section for Cell Therapy, Division for Cancer Treatment, Oslo University Hospital.

30th October 2024 - A Tribute to Professor Kristian BergInnovative Approaches for Cancer Targeting

Kristian Berg
Kristian Berg

On the occasion of Professor Kristian Berg’s retirement, the Institute for Cancer Research and Oslo Cancer Cluster are pleased to announce the symposium “Innovative Approaches for Cancer Targeting” 30th October 2024.

We are proud to present an extraordinary program in the intersection of Reactive Oxygen Species, Photomedicine, Endocytosis and Antibody Drug Conjugates (ADCs). The program includes national and international speakers and has high focus on innovation and clinical implementation of research findings.

Announcement: UiO Growth House hangout Oct 10Innovation hangout for academia and industry

Welcome to this meeting place where we want to inspire researchers and students, give them self-confidence and knowledge about the innovation process, help them build networks, and facilitate collaboration between academia and industry. This hangout is a collaboration with Health2B and The Intervention Centre at Oslo University Hospital.

Time and place: Oct. 10, 2024 5:00 PM – 8:00 PM, Oslo Science Park

Inspirational talk by Erik Fosse, MD, PhD, CEO, Norwac; Professor emeritus, University of Oslo; former head of the Intervention Centre, Oslo University Hospital
Role model talk by Egidijus (Egis) Pelanis, MD, PhD, the Intervention Centre, Oslo University Hospital

HEV vaccine trial results published in Lancet

Susanne G. Dudman
Susanne G. Dudman

Hepatitis E virus (HEV) infection is prevalent around the world, especially affecting low-income countries in Asia and Africa. High morbidity and mortality have been reported in pregnant women and their children. The only licensed vaccine against HEV, the recombinant HEV239, has been used in a large RCT in Bangladesh. The results from the clinical trial were published in Lancet recently. Senior author is Susanne G. Dudman, head of the The Clinical Virology Research Group group at the Department of Microbiology.

Ragnhild A. Lothe honoured by the Porto City Council

With the nominators: Professors Manuel Sobrinho-Simoes, Manuel R. Teixeira, and Leonor David after the ceremony
With the nominators: Professors Manuel Sobrinho-Simoes, Manuel R. Teixeira, and Leonor David after the ceremony

The Porto Municipal Medals ceremony for 2024 was held on July 9th, recognising several individuals and institutions for their distinguished merits and civic achievements. Among the recipients of the Medal of Merit - Gold grade, was Professor Ragnhild A. Lothe from the Norwegian Radiumhospital - Institute for Cancer Research. Professor Lothe has played pivotal role in over 30 years of collaboration with scientists and clinicians at medical institutions in Porto, including IPATIMUP, the Portuguese Oncology Institute, and the University of Porto. This collaboration has resulted in numerous joint scientific papers, PhD degrees, innovation projects, and exchanges of scientific and technological expertise.

The Mayor, Rui Moreira, and the President of the Minicipal Assembly, Sebestião de Azevedo, presented the medal in the presence of the municipal executive council.

Publication in Nature Immunology from Malmberg group

First author Herman Netskar and senior author Karl Johan Malmberg
First author Herman Netskar and senior author Karl Johan Malmberg

A paper entitled "Pan-cancer profiling of tumor-infiltrating natural killer cells through transcriptional reference mapping" was published in the highly ranked journal Nature Immunology on July 2. This work will be an important resource when designing new NK cell therapies.
The authors have been analyzing transcriptional data from 427 patients and 39 datasets, including 7 solid tumor types (lung, brain, skin, pancreas, prostate, breast, sarcoma). They could identify 6 different functional states of tumor-infiltrating NK cells, and the state of the NK cells correlate with survival for cancer patients. 

Skotland and Sandvig with comment on lipidomics in Nature Reviews Molecular Cell Biology

Tore Skotland and Kristen Sandvig
Tore Skotland and Kristen Sandvig

Tore Skotland and Kirsten Sandvig, Department of Molecular Cell Biology, Institute for Cancer Research, have together with four international experts on mass spectroscopy (MS) analyses of lipids, published a short comment (2 pages with a supplementary of 2 pages) in Nature Reviews Molecular Cell Biology.

The article is entitled “Pitfalls in lipid mass spectroscopy of mammalian samples – a brief guide for biologists”. 

 

Best Paper Award at the 2024 IEEE International Conference on CommunicationsOptimizing Drug Delivery with Advanced Techniques

Mohammad Zoofaghari, Martin Damrath, Mladen Veletic and Ilangko Balasingham
Mohammad Zoofaghari, Martin Damrath, Mladen Veletic and Ilangko Balasingham

A team from the Wireless Sensor Network Research Group at The Intervention Center, led by Prof. Ilangko Balasingham, won the Best Paper Award at the 2024 IEEE International Conference on Communications (ICC).
The 6-page paper, entitled "Ultrasound-enabled SIMO Channel for Targeted Brain Cancer Chemotherapy", presents a novel scheme for effectively delivering drugs across the blood-brain barrier to treat glioblastoma. It was selected from 2,340 submissions and was among only 13 to receive this prestigious recognition. 

 


More news from the archive